(HealthDay) -- For patients with acute myocardial infarction (AMI), pretreatment with angiotensin receptor blockers (ARBs) is linked with reduced incidence of the no-reflow phenomenon after percutaneous coronary intervention ...
Apr 24, 2012
0
0
Published in today's Medical Journal of Australia, the study of 2898 patients (2183 men, 715 women) reveals that six months after hospital discharge, death rates and serious adverse cardiovascular events in women presenting ...
Jul 22, 2018
0
7
(HealthDay)—For patients with acute coronary syndrome, phosphate-buffered tirofiban, but not citrate-buffered tirofiban, is associated with an increased risk of thrombocytopenia, according to a study published in the Aug. ...
Aug 16, 2016
0
1
Personalised management is the only way to close the mortality gap for patients with atrial fibrillation (AF), according to an ESC consensus paper presented at ESC Congress 2013 by Professor Paulus Kirchhof (UK).
Aug 27, 2013
0
0
A study of more than 1 million Swedish men followed for up to 50 years found that higher blood pressure (BP) at age 18 was associated with an increased risk for major cardiovascular events later in life, including heart failure, ...
Sep 25, 2023
0
3
A new study finds that digital health interventions can help reduce blood pressure when used in populations experiencing health disparities. The paper, "Digital Health Interventions for Hypertension Management in US Populations ...
Feb 20, 2024
0
0
(Medical Xpress)—A single combination pill could reduce cardiovascular disease and stroke in Latin Americans by up to 21 percent at a cost of about $35 per quality adjusted life year gained, according to a study led by ...
Jan 16, 2013
0
0
(HealthDay)—Use of transradial access (TRA) for ST-elevation myocardial infarction (STEMI) percutaneous coronary intervention (PCI) increased from 2009 to 2015, with considerable geographic, operator, and institutional ...
Nov 3, 2017
0
0
(HealthDay)—Use of clinical decision support systems (CDSSs) is associated with improvements in reversible risk for cardiovascular disease (CVD) among patients with the highest levels of baseline risk, according to a study ...
Feb 11, 2022
0
16
Drug-coated devices (DCDs) are not associated with increased long-term mortality among older patients who undergo femoropopliteal artery revascularization, according to a research letter published online May 20 in Circulation: ...
Jun 1, 2022
0
3
